# GlaxoSmithKline plans £90M aseptic manufacturing facility in Barnard Castle

GlaxoSmithKline announced plans to spend more than £90 million on a new aseptic manufacturing facility at its Barnard Castle site in County Durham, UK, to produce injectable liquids for HIV, respiratory and autoimmune diseases. Planning permission is still required, with construction expected to begin in 2020.

- Type: Expansion
- Announced: 2016-11-09
- Where: Barnard Castle, County Durham, United Kingdom
- Value: $111.6M (90.0M GBP)
- Status: announced
- Products: injectable liquids for HIV, respiratory and autoimmune diseases
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GlaxoSmithKline](https://endata.com/companies/5584.md)

## Sources

- [thenorthernecho.co.uk](https://www.thenorthernecho.co.uk/business/spotlighton/14876650.glaxo-site-still-thriving-years/), 2016-11-09: "Earlier this year, GlaxoSmithKline revealed plans to spend more than £90m on what it calls an aseptic manufacturing facility, which will supply injectable liquids for things like HIV, respiratory and autoimmune diseases."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.